T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor

Antigen and Lymphopenia-Driven Donor T Cells Are Differentially Diminished by Post-Transplantation Administration of Cyclophosphamide after Hematopoietic Cell Transplantation

(2013) Duncan Ross et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Partially Mismatched Transplantation and Human Leukocyte Antigen Donor-Specific Antibodies

(2013) Douglas E. Gladstone et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis

(2013) Jennifer A. Kanakry et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

New insights into HIV impact on hematopoiesis

(2013) R. Akkina   BLOOD

Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas

(2013) P. E. Massa et al.   BLOOD

Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma

(2013) A Raiola et al.   BONE MARROW TRANSPLANTATION

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

(2013) Asad Bashey et al.   JOURNAL OF CLINICAL ONCOLOGY

Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

(2013) C. G. Kanakry et al.   Science Translational Medicine

Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

(2012) Stefan O. Ciurea et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

(2012) Scott R. Solomon et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning

(2012) Anna Maria Raiola et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study

(2012) B. Federmann et al.   HAEMATOLOGICA

Immune Reconstitution after Double Umbilical Cord Blood Stem Cell Transplantation: Comparison with Unrelated Peripheral Blood Stem Cell Transplantation

(2011) Caron A. Jacobson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing

(2011) D. Grosso et al.   BLOOD

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

(2011) C. G. Brunstein et al.   BLOOD

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

(2011) M. Di Ianni et al.   BLOOD

Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases

(2011) A. Ruggeri et al.   Transplant Infectious Disease

Donor-Derived Second Hematologic Malignancies after Cord Blood Transplantation

(2010) Karen K. Ballen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation

(2009) Xiao-Jun Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome

(2009) Yvette L. Kasamon et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Improved Survival with Inhibitory Killer Immunoglobulin Receptor (KIR) Gene Mismatches and KIR Haplotype B Donors after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation

(2009) Heather J. Symons et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

(2008) Lauri M. Burroughs et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

(2008) F. Ciceri et al.   BLOOD